ROCKLAND, Mass.--(BUSINESS WIRE)--BioSphere Medical, Inc. (NASDAQ: BSMD), a medical device company that has pioneered the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations, announced today that Richard Faleschini, President and Chief Executive Officer, is scheduled to present at the BMO Capital Markets 2007 Focus on Healthcare Conference on Tuesday, December 4, 2007 at 3:30 pm Eastern Time. The event is taking place at the Millennium Broadway Hotel in New York City.
